Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06133101
PHASE2

Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)

Sponsor: Marialena Mouzaki

View on ClinicalTrials.gov

Summary

A randomized, controlled study of standard soy milk consumption compared to 2% fat cow's milk consumption in children with Non-alcoholic Fatty Liver Disease (NAFLD). The investigators hypothesize that the daily consumption of soy isoflavones found in the soy milk will be beneficial in reducing NAFLD and other obesity-related comorbidities. The investigators do not expect any adverse endocrine or metabolomic effects from the consumption of soy isoflavones.

Key Details

Gender

All

Age Range

5 Years - 12 Years

Study Type

INTERVENTIONAL

Enrollment

44

Start Date

2024-01-15

Completion Date

2026-06

Last Updated

2024-08-20

Healthy Volunteers

No

Interventions

DRUG

Standard Soy Milk

Consumption of commercially available soy milk

DRUG

2% Fat Cow's Milk

Consumption of commercially available 2% cow's milk

Locations (1)

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States